Literature DB >> 1095102

Oestrogen therapy and serum cortisol in carcinoma of the prostate.

A Morales, A S Kraus, A W Bruce.   

Abstract

Patients with prostatic cancer, receiving oestrogen therapy were found to have elevated serum cortisol levels and lymphopenia. Oestrogens are known to have a profound effect on the immune system; the possibility that this effect is mediated through the adrenal cortex is discussed. The significance of these findings, however, remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1095102     DOI: 10.1111/j.1464-410x.1975.tb03966.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  2 in total

1.  Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC).

Authors:  Tahir Latif; Laura Wood; Cindy Connell; David C Smith; David Vaughn; David Lebwohl; David Peereboom
Journal:  Invest New Drugs       Date:  2005-01       Impact factor: 3.850

2.  The choice of estrogen preparations in the treatment of prostatic cancer.

Authors:  A Morales; B Pujari
Journal:  Can Med Assoc J       Date:  1975-11-08       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.